Author

A. L. Garfall

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Gutierrez Uzquiza· 1 shared A. Illendula· 1 shared A. Saraf· 1 shared D. Vogl· 1 shared J. H. Bushweller· 1 shared L. Bernabei· 1 shared L. Busino· 1 shared L. Florens· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gutierrez Uzquiza

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

N. Zhou, A. Gutierrez Uzquiza, X. Y. Zheng, D. Vogl, A. L. Garfall, L. Bernabei, A. Saraf, L. Florens, M. P. Washburn, A. Illendula, J. H. Bushweller, L. Busino

This study identifies RUNX1 and RUNX3 as proteins that protect IKZF1 and IKZF3 from lenalidomide-induced degradation, thereby reducing the effectiveness of lenalidomide in multiple myeloma.

bioRxiv · Sep 20, 2018Cancer Biology